GLP-1 medications get a lot of coverage for what they do — the weight loss, the blood sugar improvements, the appetite suppression. They get less honest coverage about what they feel like to take, particularly in the early weeks.
Here’s a straightforward account of the side effects, based on the clinical trial data and what patients consistently report.
The common side effects
The most prevalent side effects of GLP-1 medications are gastrointestinal. Nausea is the most common, reported by 15–44% of participants in major trials depending on the drug and dose. Vomiting occurs in 5–24% of people. Diarrhea and constipation are both reported — yes, both — often alternating.
These effects are most pronounced during the dose escalation phase. Both semaglutide and tirzepatide are started at low doses and gradually increased over weeks to months to minimize GI disruption. The nausea tends to peak in the first few weeks after a dose increase and then fade as the body adjusts.
For most people, these effects are manageable but unpleasant. For a meaningful minority — roughly 5–10% in clinical trials — they’re severe enough to discontinue treatment.
Practical strategies that help: eating smaller meals, eating slowly, avoiding high-fat foods (which are harder to digest when gastric emptying is slowed), staying hydrated, and not eating lying down. Some physicians recommend anti-nausea medications in the first weeks if symptoms are severe.
The less-discussed side effects
A few effects don’t get as much coverage.
Fatigue: Many people report significant fatigue in the first weeks. This is partly from reduced calorie intake (the appetite suppression often cuts food intake dramatically) and partly from the adjustment to the medication itself. It typically improves as the body adapts and eating patterns stabilize.
Muscle loss: Rapid weight loss from any cause involves loss of both fat and muscle mass. Studies of GLP-1 medications have found that a significant portion — roughly 25–40% — of weight lost on these drugs is lean mass rather than fat. This is concerning for older adults, in whom muscle preservation is particularly important. High protein intake and resistance exercise are the standard recommendations to minimize muscle loss on these medications.
Hair thinning: Shedding more hair than usual, a condition called telogen effluvium, has been reported by many patients and is now recognized as a side effect. It appears to be related to rapid weight loss rather than the drug itself, and in most cases it resolves as weight stabilizes.
Heart rate elevation: Semaglutide is known to increase resting heart rate by an average of 1–4 beats per minute. This is usually not clinically significant, but it’s worth knowing about if you’re monitoring heart rate for other reasons.
Serious but rare risks
The FDA label for GLP-1 medications includes a warning about medullary thyroid cancer based on rodent studies — people with a personal or family history of this rare cancer or of MEN2 syndrome should not use these drugs.
Pancreatitis has been reported, though the evidence on whether GLP-1 medications actually cause it (versus being associated with populations already at risk) is contested. Gallbladder disease, including gallstones, is elevated — rapid weight loss of any kind increases gallstone risk.
The serious risks are rare. The common side effects are not. Going in with realistic expectations about what the first month or two will feel like makes it more likely you’ll stay on the medication long enough to see the benefits.
This content is for educational purposes only and is not medical advice. Consult your healthcare provider before making changes to your diet, supplements, or medications.
